Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
2012
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
268
Citations
NaN
KQI